Congenital Heart Disease (CHD), known locally as Penyakit Jantung Bawaan (PJB), remains a significant public health challenge in Indonesia, contributing to a substantial portion of neonatal mortality across the archipelago. During a comprehensive webinar hosted on February 14, 2023, Dr. Rizky Adriansyah, MKed, a prominent pediatric specialist and Chairman of the Cardiology Coordination Unit of the Indonesian Pediatric Society (IDAI), highlighted the complexities surrounding the condition. While the definitive cause of CHD often remains elusive to medical science, Dr. Adriansyah emphasized that identifying and mitigating specific risk factors during pregnancy is the most effective strategy for reducing the incidence of these cardiac anomalies in newborns.
The medical community categorizes CHD as a structural problem in the heart that is present at birth. These defects can range from simple conditions that might not cause symptoms to complex defects that are life-threatening. In the Indonesian context, the struggle against CHD is twofold: preventing the occurrence through maternal health interventions and improving the dismal rate of early detection and treatment for those already born with the condition.
The Triad of Maternal Risk Factors
According to Dr. Adriansyah, contemporary medical literature has narrowed down three primary risk factors that expectant mothers must navigate with caution. While these factors do not always have a direct cause-and-effect relationship with heart defects, their correlation is strong enough to warrant strict preventive measures.
First, the presence of maternal infections, particularly the Rubella virus, is a leading concern. Rubella, also known as German measles, can have devastating effects on a developing fetus if the mother is infected during the first trimester—the critical period when the heart and other major organs are forming. This condition, known as Congenital Rubella Syndrome (CRS), often results in multiple birth defects, with heart abnormalities being among the most common.
Second, nutritional deficiencies, specifically a lack of folic acid, play a pivotal role. Folic acid is essential for DNA synthesis and cell growth. While its role in preventing neural tube defects is well-documented, emerging research and clinical observations increasingly link adequate folic acid intake to the proper development of the heart’s chambers and valves.
Third, the consumption of certain medications during pregnancy can interfere with fetal development. Dr. Adriansyah specifically pointed to anti-seizure medications (anticonvulsants) as a high-risk category. When a pregnant woman requires treatment for epilepsy or other neurological conditions, the pharmacological intervention must be carefully managed by a multidisciplinary team of neurologists and obstetricians to minimize the risk of teratogenic effects on the fetal heart.
Shifting Paradigms in Prevention and Lifestyle
Historically, public health messaging regarding birth defects focused heavily on the consumption of alcohol and tobacco. While Dr. Adriansyah acknowledged that smoking and alcohol consumption remain significant risk factors, he noted a puzzling trend: many cases of CHD occur in children whose mothers did not smoke or drink. This realization has shifted the focus toward a more holistic view of maternal health that includes vaccination and proactive supplementation.
The prevention of CHD must occur before and during pregnancy. Once a child is born with a heart defect, the window for prevention has closed, and the medical focus must shift entirely to management and surgical intervention. "This is why prevention during pregnancy is vital," Dr. Adriansyah stated. He urged women of childbearing age to ensure their Rubella vaccinations are up to date before conceiving and to maintain a diet rich in essential nutrients supplemented by folic acid throughout the gestational period.
The Statistical Burden in Indonesia
The scale of CHD in Indonesia is reflected in grim statistics. Data from 2017 indicates that CHD is the second leading cause of neonatal death in the country, accounting for 17 percent of all fatalities in the first month of life, surpassed only by complications related to prematurity. This aligns with global data provided by the World Health Organization (WHO), which suggests that approximately one in every 100 newborns suffers from some form of CHD.
Of these cases, roughly 25 percent are classified as "Critical Congenital Heart Disease" (CCHD). CCHD refers to defects that require surgical or catheter intervention within the first year—often within the first days or weeks—of life to ensure survival. In Indonesia, this translates to an estimated two to four critical cases for every 1,000 live births. Given Indonesia’s high birth rate, this represents thousands of infants annually who require immediate, specialized medical attention.
Barriers to Treatment and the "50 Percent Gap"
Perhaps the most distressing revelation from the IDAI Cardiology Coordination Unit is that less than 50 percent of CHD cases in Indonesia are currently being handled or treated effectively. This massive gap in the healthcare system is attributed to a combination of systemic and social factors.
- Geographical and Financial Access: As an archipelagic nation, Indonesia faces unique logistical hurdles. Specialized cardiac centers are predominantly located in major urban hubs on the island of Java, leaving families in remote provinces with limited access to life-saving surgeries. While the national health insurance scheme (BPJS Kesehatan) covers many procedures, the indirect costs of travel and long waiting lists remain prohibitive for many.
- Infrastructure and Equipment: Many regional hospitals lack the advanced diagnostic tools, such as high-resolution echocardiography machines, necessary to identify complex heart structures in tiny neonates.
- Human Resource Constraints: There is a significant shortage of pediatric cardiologists and cardiovascular surgeons in Indonesia. The ratio of specialists to the population remains far below the recommendations of international health bodies.
- Public Awareness: Many parents are unaware of the subtle signs of heart distress in infants, leading to delayed consultations. By the time a child is brought to a specialist, the window for an optimal surgical outcome may have narrowed.
Innovations in Early Detection: The Role of Pulse Oximetry
To combat the high mortality rate, the medical community is advocating for simpler, more accessible screening methods. While echocardiography remains the gold standard for diagnosis, it is expensive and requires specialized training to interpret. In contrast, pulse oximetry has emerged as a sensitive, fast, and cost-effective screening tool.
Dr. Adriansyah explained that by placing an oximeter on the infant’s right hand and either foot, healthcare providers can detect differences in oxygen saturation levels. A significant discrepancy or a low overall oxygen reading can indicate the presence of a critical heart defect before the infant even shows physical signs of distress like cyanosis (bluish skin). This screening is non-invasive and can be performed in less than five minutes.
The IDAI is actively encouraging health workers at the primary care level, including midwives in village health centers (Puskesmas), to adopt this screening protocol. Early detection is particularly crucial for "silent" defects that may not produce a heart murmur audible through a stethoscope.
Clinical Symptoms and Parent Education
Parents are the first line of defense in identifying CHD after a child leaves the hospital. One of the most common clinical symptoms of a heart defect in infants is "failure to thrive" or slow weight gain. Because the heart has to work significantly harder to pump blood, the infant burns more calories and may become too exhausted to feed properly. Other symptoms include rapid breathing, excessive sweating during feeding, and a persistent cough.
To bridge the education gap, Dr. Adriansyah pointed to digital resources such as the YouTube channel "Sehatkan Jantung Anak Indonesia" (Heal the Hearts of Indonesian Children). This platform provides visual guides for both parents and healthcare workers on how to recognize symptoms and perform basic screenings. The goal is to democratize medical knowledge so that a child’s location or a family’s socioeconomic status does not determine their chance of survival.
Analysis of Implications and Future Outlook
The persistence of CHD as a leading killer of infants has profound implications for Indonesia’s human capital and economic future. Children with untreated or late-treated CHD often face lifelong developmental delays and reduced physical capacity, placing a long-term strain on the healthcare system and social services.
However, the shift toward emphasizing Rubella vaccination and folic acid supplementation represents a proactive turn in public health policy. If the Indonesian government can successfully integrate pulse oximetry screening into the standard postnatal care package nationwide, the 50 percent treatment gap could begin to close.
The challenge ahead lies in the decentralization of specialized care. While training midwives to detect CHD is a vital first step, the system must also ensure that once a defect is detected, there is a clear, rapid referral pathway to a facility capable of performing neonatal heart surgery. Without an increase in the number of pediatric cardiac centers and specialists, early detection will only lead to longer waiting lists.
In conclusion, the fight against Congenital Heart Disease in Indonesia requires a multi-faceted approach. It begins with maternal health and the simple act of vaccination, continues with the vigilant use of technology like pulse oximeters in every delivery room, and culminates in a robust surgical infrastructure. As Dr. Adriansyah and the IDAI have signaled, the tools for prevention and detection are available; the task now is to ensure they reach every corner of the nation to protect the hearts of the next generation.
